CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)

PHASE2TerminatedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2006

Conditions
Coronary DiseaseHeart Valve Diseases
Interventions
DRUG

CTI-01 (ethyl pyruvate)

Trial Locations (17)

10016

NYU Medical Center, New York

19104

Hospital of the University of Pennsylvania, Philadelphia

19380

Chester County Hospital - The Cardiovasular Center, West Chester

20010

Washington Hospital Center, Washington D.C.

21801

Peninsula Regional Medical Center, Salisbury

27710

Duke University Medical Center, Durham

27834

East Carolina University - Brody School of Medicine, Greenville

32610

University of Florida, Gainesville

53295

Medical College of Wisconsin - VA Medical Center, Milwaukee

67208

Research Support Personnel, Wichita

68114

Nebraska Methodist Hospital, Omaha

77030

St. Luke's Episcopal Hospital/Texas Heart Institute, Houston

90033

University of Southern California, Los Angeles

92653

Saddleback Memorial Medical Center, Laguna Hills

94115

Kaiser Permanente, San Francisco

98405

MultiCare Health System, Tacoma

01199

Baystate Medical Center, Springfield

Sponsors
All Listed Sponsors
lead

Critical Therapeutics

INDUSTRY